Reig Jofre, strategic partner in the stabilization and production of the first recombinant veterinary vaccine against Leishmaniasis, by Laboratorios Leti
3 May 2017
- Reig Jofre has collaborated over the past seven years with Laboratorios LETI in the industrial development of the first recombinant veterinary vaccine against leishmaniasis, a biotechnological active for which stabilization processes are highly complex.
- From now on, Reig Jofre will produce for Laboratorios LETI this biotech vaccine developed from protein Q, which Laboratorios LETI plans to commercialize internationally.